August 28, 2013: U.S. markets opened mixed Wednesday morning as the potential for a military conflict in Syria dominated the news. Crude oil prices spiked overnight�and there were other setbacks as well, like another dive by the Indian rupee. Applications for mortgages fell again as interest rates continued their climb�and U.S. crude oil inventories did not rise enough to slow the rise in crude prices. WTI closed up 1% today at $110.10 a barrel, its highest close in more than two years.
European and Latin American markets closed mixed today, while Asian markets closed lower.
Thursday�� calendar includes a speech by Richmond Fed President Jeffrey Lacker and St. Louis Fed President James Bullard plus the following data releases and events:
8:30 a.m. – U.S. GDP 8:30 a.m. – New claims for unemployment benefits 10:30 a.m. – EIA weekly natural gas storage report 1:00 p.m. – 7-year note auction 4:30 p.m. – Fed balance sheet and money supplyWe also broke out the top Wall Street calls with analyst upgrades�and analyst downgrades.
Top Services Companies For 2015: Royal Gold Inc.(RGLD)
Royal Gold, Inc., together with its subsidiaries, acquires and operates precious metals royalties. The company owns royalty interests in various production, development, evaluation, and exploration stage projects, which explore for gold, silver, copper, lead, and zinc metals. It holds royalty interests in properties located in the United States, Argentina, Australia, Bolivia, Brazil, Burkina Faso, Canada, Chile, Colombia, the Dominican Republic, Finland, Ghana, Guatemala, Honduras, Mexico, Nicaragua, Peru, the Russia Federation, Spain, and Tunisia. The company was founded in 1981 and is based in Denver, Colorado.
Advisors' Opinion:- [By Ben Levisohn]
If anything calls the higher-rates excuse into question its the strong performance of gold stocks. Royal Gold (RGLD) gained 6.3% to $61.53 and Newmont Mining (NEM) jumped 4% to $33.32. If yields were really heading higher, hold stocks should fall, though these days, I’m not really sure of anything. Homebuilders, another group that has been punished by rising yields, also surged higher today.
- [By Ben Levisohn]
Chidley cut African Barrick Gold to Underweight from Neutral courtesy of the stocks 22% rise since the beginning of December. Better bets include�Royal Gold (RGLD) and Randgold Resources (GOLD), among others, Chidley says.
- [By Travis Hoium]
What: Gold and silver miners are taking it on the chin today. Royal Gold (NASDAQ: RGLD ) fell as much as 10.4%, Allied Nevada Gold (NYSEMKT: ANV ) fell up to 11.5%, and Silver Wheaton (NYSE: SLW ) dropped as much as 11.2%.
Best Asian Stocks For 2014: NIC Inc. (EGOV)
NIC Inc. provides eGovernment services that enable governments use the Internet to provide various services to businesses and citizens in the United States. It operates in two segments, Portal Outsourcing, and Software and Services. The Portal Outsourcing segment enters into long-term contracts with governments to design, build, and operate Web-based enterprise-wide portals on their behalf. These portals consist of Web sites and applications that enable businesses and citizens to access government information online and complete transactions, including applying for a permit, retrieving driver?s history records, and filing a government-mandated form or report. The Software and Services segment involves in the software development and services to state and local governments, and federal agencies; development and management of the national motor carrier pre-employment screening program; design and development of online campaign expenditure and ethics compliance systems for fe deral and state government agencies; and provision of software applications and services for electronic filings and document management for the California Secretary of State. It also provides consulting, application development, and portal management services to governments. The company was founded in 1991 and is headquartered in Olathe, Kansas.
Advisors' Opinion:- [By Michael A. Robinson]
Indeed, NIC Inc. (Nasdaq: EGOV) is an expert at building government websites that operate flawlessly. It counts 3,500 government agencies as e-government clients.
- [By CRWE]
NIC Inc.(NASDAQ:EGOV), the nation�� premier provider of eGovernment services, will discuss its 2012 second quarter financial results via a conference call on Thursday, August 2, 2012 at 4:30 p.m. (EDT), with the news release issued at 4 p.m. (EDT) the same day.
Best Asian Stocks For 2014: NVR Inc.(NVR)
NVR, Inc. operates as a homebuilder in the United States. It engages in the construction and sale of single-family detached homes, townhomes, and condominium buildings under the trade names of Ryan Homes, NVHomes, Fox Ridge Homes, and Rymarc Homes primarily to first-time homeowners and first-time move-up buyers. The company markets its products in Maryland, Virginia, West Virginia, western and eastern Pennsylvania, New York, North Carolina, South Carolina, Ohio, New Jersey, Delaware, Indiana, Kentucky, Florida, Tennessee, and Columbia. It also offers mortgage banking services to its homebuilding customers, including mortgage financing and brokerage of title insurance, as well as performs title searches in connection with mortgage loan closings. NVR, Inc. was founded in 1979 and is headquartered in Reston, Virginia.
Advisors' Opinion:- [By Sally Jones]
NVR Inc. (NVR): Reduced
Up 9% over 12 months, NVR Inc., a residential construction company, has a market cap of $4.41 billion. The current share price is around $969.98. Shares trade at a P/E of 20.70. The company does not pay a dividend.
- [By Morgan Housel]
This isn't surprising. The supply of existing homes for sale is at a seven-year low. Construction of new homes is still well below the rate of household formation. Prices will almost always rise in that situation. It's simple supply and demand. And it's pulled millions of homeowners out from being underwater on their mortgage and brought new hope to the housing industry, boosting shares of D.R. Horton (NYSE: DHI ) and NVR (NYSE: NVR ) as the outlook for construction rises.�
- [By Seth Jayson]
NVR (NYSE: NVR ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), NVR met expectations on revenues and whiffed on earnings per share.
Best Asian Stocks For 2014: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Dimitra DeFotis]
Among pharma names that moved higher,�Regeneron Pharmaceuticals (REGN) rallied nearly 6% and Hospira (HSP) jumped more than 8%. And healthcare was otherwise in the headlines. Genworth Financial (GNW) was among the day’s worst performers, down 14%. Insurer Genworth likely faces higher reserves for long-term care payouts.
Best Asian Stocks For 2014: Bazaarvoice Inc (BV)
Bazaarvoice, Inc., incorporated on May 25, 2005, connects businesses together to amplify the authentic voices of people where they shop. The Company�� solutions, which are primarily provided through Software as a Service (SaaS) platform, enable clients to capture and display online word of mouth about specific products and services, channel content into all the places where it will influence a purchase both within and outside its network, which it refers to as syndication, and use business insights so they can act on what consumers want.
Bazaarvoice Conversations Platform
The Company�� Conversations platform provides capabilities to capture, manage and display online word of mouth. Consumers interact with its solutions as they view or author consumer reviews, questions, photos, videos, long-format narratives and other forms of consumer-generated content. Content that is displayed by its Conversations platform is styled to match its clients��brand, preserving important branding elements of its clients��businesses. Content collected and managed by its Conversations platform is used by its clients in a range of applications, including their online Websites, mobile-optimized Websites, mobile applications, social networks, in-store kiosks, physical in-store displays, printed flyers, email and other forms of online and offline media. The Company�� Conversations platform allows clients to capture, manage and display consumer reviews about their products and services on their Websites and mobile-optimized Websites; allows clients to facilitate question and answer conversations between consumers, or between consumers and brand representatives, on their Websites; allows clients to collect consumer testimonials about their products and services and display these stories on their Websites; enables consumers to read or write reviews, product questions, product answers, or stories on its clients��pages on social networking Websites and easily share this content with the peopl! e they influence the most-their social network friends or followers, and provides third-party developers with tools to build products or extend its platform on behalf of its clients, which enables the Company to expand the use of its platform by leveraging applications built by third-party developers.
Bazaarvoice Connections Solutions
The Company�� Conversations clients are connected through its SaaS platform to form a network. The Company offers network syndication and brand engagement solutions to facilitate the sharing of online word of mouth among its clients and to enable brands to directly interact with consumers on its retail clients��Websites. BrandVoice enables brands to enter into distribution relationships allowing them to display review content from their brand Websites on retail Websites within its network, which it refers to as syndication. BrandAnswers enables brands to interact directly with consumers on retail websites within its network to answer questions and provide suggestions on alternative products that may better meet that consumer�� needs. Brand Response enables brands to interact with consumers by responding to reviews posted on retail Websites within its network.
Bazaarvoice Analytics Solutions
The Company�� Conversations platform includes its Intelligence solution, which is it enhanced analytics solution, and a Workbench Analytics solution, which provides analytics and self-service administration tools. Intelligence allows clients to derive sophisticated market, consumer and product insights in a timely manner from the underlying data it collects on their behalf through its platform. Workbench Analytics provides basic analytics capabilities that allow its clients to generate reports highlighting simple ratings trends, text analysis and product and service issue identification.
Bazaarvoice Media
The Company�� Bazaarvoice Media sells advertising on behalf of retailers, brands and agencie! s, and pr! ovides capabilities that incorporate consumers��authentic opinions in advertising campaigns, creating advertisements that are trusted, relevant and targeted. Bazaarvoice Media sells advertising on retail Websites, utilizing its relationships and knowledge of the intricacies of the retail environment. It develops custom programs for brands to reach consumers while they are in the shopping environment, while also selling to non-retail brands, such as within the automotive and financial industries, that wish to reach the engaged shopper within this channel. Word of Mouth Advertisements provides brands with the ability to increase engagement with their advertising through the inclusion of authentic consumer sentiment. Mobile Advertising enables brands to reach consumers on their mobile devices.
The Company competes with Pluck, Reevoo, Gigya, Viewpoints, Google and Facebook.
Advisors' Opinion:- [By Roberto Pedone]
Another earnings short-squeeze prospect is Bazaarvoice (BV), a provider of social commerce software solutions, which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect Bazaarvoice to report revenue of $44.12 million on a loss of 8 cents per share.
The current short interest as a percentage of the float for Bazaarvoice is very high at 14.4%. That means that out of the 41.18 million shares in the tradable float, 6.33 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 11.6%, or by 656,000 shares. If the bears are caught pressing their bets into a bullish quarter, then shares of BV could rip sharply higher post-earnings as the shorts rush to cover some of their bets.
From a technical perspective, BV is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been trending sideways inside of a consolidation pattern for the last month and change, with shares moving between $10.15 on the downside and $11.50 on the upside. Any high-volume move above the upper-end of its recent range post-earnings could trigger a major breakout trade for shares of BV.
If you're bullish on BV, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $11.35 to $11.50 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 661,797 shares. If that breakout triggers, then BV will set up to re-test or possibly take out its next major overhead resistance levels at $13 to $14 a share.
I would simply avoid BV or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below its 50-day at $10.34 a share and then below some key near-term support at $10.15 a share with high volume. If we get that m
Best Asian Stocks For 2014: WisdomTree SmallCap Earnings Fund (EES)
WisdomTree SmallCap Earnings Fund (the Fund) seeks investment results that correspond to the price and yield performance of the WisdomTree SmallCap Earnings Index (the Index). The Index is a fundamentally weighted index that measures the performance of earnings-generating companies within the small-capitalization segment of the United States stock market. The Index consists of the companies in the bottom 25% of the market capitalization of the WisdomTree Earnings Index after the 500 largest companies have been removed. Companies must be incorporated and listed in the United States, and must have generated positive cumulative earnings over their most recent four fiscal quarters prior to the Index measurement date. The Index is earnings-weighted in December to reflect the proportionate share of the aggregate earnings each component company has generated. Companies with greater earnings generally have larger weights in the Index. Its investment advisor is WisdomTree Asset Management, Inc. Advisors' Opinion:- [By Philip Springer]
WisdomTree SmallCap Earnings Fund (EES) follows earnings generated by companies in the small-cap universe of the US stock market.
Furthermore, the fund looks to weight by earnings, giving bigger weights to firms that earn more, irrespective of market capitalization.
No comments:
Post a Comment